Home › Funds › Almitas Capital LLC › AMLX

Almitas Capital LLC position in AMLX

AMYLYX PHARMACEUTICALS INC · Health Care

Almitas Capital LLC reported holding 974,881 shares of AMLX (AMYLYX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$17.5M, representing 4.20% of its reported portfolio and ranking #4 among its reported holdings. Almitas Capital LLC has disclosed AMLX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)974.88K sh
Reported value held$17.51M
Portfolio Weight4.20%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Almitas Capital LLC's AMLX position evolved

Almitas Capital LLC first disclosed a stake in AMLX in Q2 2024 at 1,903,851 shares (US$3.6M). The position peaked in Q1 2026 at 2,122,597 shares, worth US$29.5M. Across 9 filings, Almitas Capital LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 974,881 shares valued at US$17.5M — a reduction of -1,147,716 shares quarter over quarter.. Notable position changes include a 54% trim in Q2 2026 (shares rose 62% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.90M $3.62M New
Q3 2024 1.99M $6.44M Add
Q4 2024 2.03M $7.68M Add
Q1 2025 2.12M $7.51M Add
Q2 2025 2.12M $13.61M Hold
Q3 2025 2.12M $28.85M Hold
Q4 2025 2.12M $25.64M Hold
Q1 2026 2.12M $29.50M Hold
Q2 2026 974.88K $17.51M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMLX and 13F data

AMLX (AMYLYX PHARMACEUTICALS INC) is a Health Care company. 50 other funds we track also report a position in AMLX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$149.7M), TCG Crossover Management, LLC (US$112.1M), Commodore Capital LP (US$101.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMLX

All AMLX fund holders →

FAQ

How long has Almitas Capital LLC held AMLX?

Almitas Capital LLC has disclosed AMLX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Almitas Capital LLC's current position in AMLX?

As of Q2 2026, Almitas Capital LLC holds 974.88K shares of AMLX (AMYLYX PHARMACEUTICALS INC), valued at $17.51M, representing 4.20% of its reported portfolio and ranking #4.

Has Almitas Capital LLC been buying or selling AMLX?

In the latest 13F filing (Q2 2026), Almitas Capital LLC reduced its position in AMLX. The position peaked in Q1 2026 at 2.12M shares.

Which other funds hold AMLX?

Other major institutional holders of AMLX include PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, Commodore Capital LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.